logo-loader
viewImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies on an aggressive sales and business development drive

ImmunoPrecise Antibodies Ltd's (CVE:IPA) president and chief executive Jennifer Bath caught up with Proactive Investors at the Spring Investor Summit 2019 in New York City.

Operating from their laboratory facilities at the Vancouver Island Technology Park in Victoria, British Columbia …  ImmunoPrecise is an 'end-to-end' provider for accelerated antibody research and discovery.

Quick facts: ImmunoPrecise Antibodies Ltd

Price: 0.63 CAD

TSX-V:IPA
Market: TSX-V
Market Cap: $42.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ImmunoPrecise Antibodies Ltd named herein, including the promotion by the Company of ImmunoPrecise Antibodies Ltd in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Base Resources Kwale operations enters new phase and Toliara...

Base Resources Limited (ASX:BSE) (LON:BSE) chief financial officer Kevin Balloch updates Proactive on the highlights of its half year results. The company has had a successful ramp-up of mineral sands mining operations on the South Dune ore body at the Kwale operations in Kenya and continues...

2 hours, 2 minutes ago

2 min read